JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B5615 A 844606

Summary: α7 nAChR partial agonist

insoluble in ethanol
B6238 (S)-AMPA

Summary: AMPA agonist

<18.62 mg/mL
B4909 SAR407899 hydrochloride

Summary: ATP-competitive ROCK inhibitor

Soluble in DMSO
B4985 CH5183284 (Debio-1347)

Summary: selective and orally available FGFR inhibitor

≥35.6 mg/mL
B5860 TAK960

Target: PLK

Summary: Oral and selective PLK1 inhibitor

≥28.05 mg/mL
B5863 LX7101 HCL

Summary: Dual LIM-kinase and ROCK inhibitor

insoluble in H2O; insoluble in EtOH; insoluble in DMSO
B5879 GSK2879552
1 Citation

Target: LSD

Summary: Novel and irreversible LSD1 inhibitor

insoluble in EtOH; ≥10.14 mg/mL
B1066 Dolastatin 10 trifluoroacetate

Summary: Antitumor agent

Soluble in DMSO
A8898 HZ-1157

Summary: HCV NS3/4A protease inhibitor

insoluble in H2O; ≥11.6 mg/mL
L1045 DiscoveryProbe™ TGF-beta/Smad Compound Library

Summary: A unique collection of 88 TGF-beta/Smad inhibitors for TGF-beta/Smad signaling pathway research.